Physician profile
Herbert A Hopper
NPI 1487955134
$4,835.21
in general payments reported to CMS, 2019-2025
15 companies · $1,821 in 2025
The $1,821 reported for 2025 was more than what 77% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $296 · 2021: $1,277 · 2022: $28.36 · 2023: $985 · 2024: $141 · 2025: $1,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,737 · Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,737.11 |
| Food and Beverage | $1,210.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,628.73 | 2021-2025 | Advantagerib, Ribfix Titan |
| Integra Lifesciences Corporation | $1,105.43 | 2021-2023 | Integra, Primatrix, Surgimend |
| Intuitive Surgical, INC. | $349.92 | 2025 | |
| Kls-Martin L.P. | $283.03 | 2020 | |
| Allergan, INC. | $168.56 | 2019 | |
| Portola Pharmaceuticals, LLC | $63.54 | 2019 | |
| Avita Medical Americas, LLC | $48.18 | 2025 | Recell, Cohealyx, Permeaderm |
| Atricure, INC. | $43.40 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $37.29 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Z-Medica, LLC | $23.64 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.78 | 2021 | |
| La Jolla Pharmaceutical Company | $19.37 | 2021 | |
| Csl Behring | $16.36 | 2019 | |
| Acell, INC. | $14.91 | 2019 | |
| Brainscope Company, INC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Hopper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.